UK Radical Prostatectomy Audit 2011 : A1
Persistence of response to lifestyle modification in men with prostate cancer on AST: updated results from an ongoing randomised controlled trial : A2
Active surveillance in a UK Cancer Centre - are patients being put at risk? : A3
Is treatment delay safe in individuals with low-risk prostate cancer?: Results from a nationwide population-based cohort : A4
Patients undergoing transperineal saturation prostate biopsy to assess for suitability of active surveillance are not at higher risk of complications if they proceed to radical prostatectomy : A5
True day case laparoscopic radical prostatectomy : A6
Oncological outcomes from salvage radiotherapy for biochemical recurrence after robotic assisted laparoscopic prostatectomy (RALP) : A7
Assessment of required nodal yield for accurate staging in a high risk cohort undergoing extended lymphadenectomy in robot-assisted radical prostatectomy and the impact on functional outcomes : A8
Medium term outcomes following primary focal therapy using HIFU for localised prostate cancer : A9
Salvage High Intensity Focused Ultrasound; medium term results of a minimally invasive treatment for recurrent prostate cancer after radical radiotherapy : A10
Evolution of a 1 stage real-time implant technique: 4D Brachytherapy : A11
FRAX® assessment of men treated with androgen deprivation therapy for prostate cancer : A12
Genetic profile of cystinuria in a UK population - the detection of new pathological mutations : B1
Conservative management of asymptomatic calyceal calculi: natural history : B2
Supine Percutaneous Nephrolithotomy with Endoscopic Combined Intra-renal Surgery - outcomes of the first one hundred patients treated in a single UK centre : B3
Measuring stone burden - 3D software reconstruction vs. ellipsoid algebra : B4
What is the most optimal follow up strategy for Pelvi-ureteric Junction Obstruction (PUJO) treated with Pyeloplasty? A 10 year single centre analysis : B5
Long-term comparative outcomes of endoscopic management and laparoscopic nephroureterectomy for non-invasive upper tract urothelial cancer (UTUC): 20-year single centre experience : B6
Penile prosthesis insertion in patients with refractory ischemic priapism: immediate versus delayed implantation : C1
Reconstructive Surgery for Bladder Neck Contracture (BNC) following prostate cancer treatment : C2
Sex: the new healthcare inequality : C3
Prognostic significance of extracapsular spread and its extent in inguinal nodes in penile cancer : C4
The outcome of microsurgical epididymo vasostomy in the management of obstructive azoospermia : C5
Is there a case for centralising andrological surgery in the UK? : C6
The use of Hospital Episode Statistics (HES) to demonstrate the natural history of the operative management of urethral stricture disease : C7
A population based analysis of socioeconomic circumstances and incidence of prostate cancer : P1
Can PSA density predict your risk of having prostate cancer? : P2
Can multi-parametric MRI prior to first TRUS biopsy rule out clinically important prostate cancer? A validating cohort study using template prostate mapping as a reference test : P3
Predictive value of PSA, PSAD and %free PSA for PCa diagnosis, Gleason score (GS) and Cancer Volume (CaV) in men undergoing Transperineal Template Guided Saturation Biopsy (TTSB) : P4
What is the optimum antibiotic policy for Transrectal Ultrasound guided Prostate Biopsy? : P5
Active surveillance with confidence: the place of Transperineal Sector Biopsies (TPSB) to improve risk stratification in localised prostate cancer : P6
Benign secondary transperineal sector biopsy versus MD Anderson prostate biopsies - a multicentred long term follow-up evaluation : P7
Primary Transperineal Sector Biopsies (TPSB) of the prostate: evaluation in clinical practice : P8
The role of transperineal template guided prostate biopsies in the active surveillance patient : P9
Is concurrent technetium-99m bone scintigraphy redundant in the assessment of metastatic disease in prostate cancer patients undergoing magnetic resonance imaging of the prostate? : P10
Outcomes of the rendezvous procedure for the management of complex ureteric strictures : P11
A comparison of transperitoneal laparoscopic pyeloplasty versus endopyelotomy after failed treatment for PUJ Obstruction : P12
The role of Laparoscopic Nephrectomy in the management of benign symptomatic poorly functioning renal disease : P13
Correlation between pre-operative ureteral stents, intra-operative renal pelvic pressures, and post-operative pain and sepsis in patients undergoing flexible ureteroscopy and laser lithotripsy : P14
Flexible ureteroscopy and laser under local anaesthesia with intra-ureteric bupivicaine : P15
Leak test decreases damage to flexible ureteroscopes : P16
Is a KUB x-ray necessary as part of Haematuria evaluation? : P17
Radiation dosage in management of patients with urolithiasis : P18
The patient care benefit of CT KUB over IVU as primary imaging for acute renal colic : P19
Ultrasound in Pyelonephritis - is there a role? a single centre experience : P20
Pathways analysis in kidney cancer using proteomics approach : P21
Development and Characterisation of a Bladder Cancer Model : P22
Hypoxia regulated miRNAs in bladder cancer : P23
Evaluation of molecular markers for predicting risk of progression in high grade non-muscle invasive bladder cancer (HGNMIBC) using automated quantitative analysis : P24
Selective activation of feline pudendal nerve with a Transdermal Amplitude-Modulated Signal (TAMS) using skin surface electrodes to inhibit bladder activity : P25
Use of the isolated perfused whole pig bladder for investigating spontaneous contractions : P26
The effect of botulinum toxin type A on synatosomal-associated protein 25 and neuropeptide Y immunoreactivity : P27
Urinary ERG immunocytochemistry can identify prostate cancer patients prior to prostate biopsy : P28
Towards derivation of a distinct signature permitting personalised treatment in prostate cancer : P29
Tyrosinase single nucleotide polymorphisms affect susceptibility to and outcome to prostate cancer : P30
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis : P31
Circulating miR-141 as a diagnostic biomarker for prostate cancer and for monitoring response to treatment : P32
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer : P33
Comparative genomics and phylogenetic foot-printing of androgen response elements in human, murine and canine degradome genes : P34
Composition of urinary tract calculi: analysis of 6 year data at a UK referral centre : P35
Stone biochemical composition but without a stone to analyse : P36
Diabetes in asian and caucasian patients with nephrolithiasis : P37
Significance of white cell count in ureteric colic? : P38
A multicentre UK-wide snapshot of current practice of stenting after ureteroscopy for stone disease : P39
Single-center analysis of complications of Holmium: YAG laser lithotripsy for upper tract calculi in 600 consecutive procedures : P40
Strategies to reduce emergency admission after extracorporeal shockwave lithotripsy : P41
The use of entonox analgesia during Extracorporeal Shockwave Lithotripsy (ESWL) using a Dornier Delta II Lithotripter : P42
Is PCNL safe in solitary kidneys? : P43
Minimally invasive techniques for stone clearance in anomalous kidneys and in patients with musculoskeletal abnormalities : P44
Changing the gold standard in the management of large renal calculi - the cost based argument : P45
Snapshot of transurethral resection in the UK audit (STUKA) : P46
Hexaminolevulinate (HEXVIX) Photodynamic Diagnosis Assisted transurethral bladder cancer surgery - multicentre experience of the UK PDD Users Group : P47
The impact of early re-resection in patients with high grade non-muscle invasive bladder cancer - an analysis of 490 consecutive patients : P48
Early re-resection of high grade nonmuscle-invasive urothelial carcinoma of the bladder (NMIBC): a 5 year experience (2007-2011) of safety and quality : P49
Initial experience with sequential BCG/Electro-motive drug administration (EMDA) Mitomycin-C (MMC) as the standard intravesical regimen for high risk non-muscle invasive bladder cancer (NMIBC) : P50
BCG resistant high risk non muscle invasive bladder cancer treated with thermochemotherapy - two year follow-up data from a single institution : P51
Can presence of granuloma act as a marker of response to intravesical BCG in non-muscle invasive bladder cancer? : P52
Prostatic urethral biopsy before cystectomy: a service evaluation : P53
UK Radical Cystectomy Audit 2011-2012 On behalf of BAUS Section of Oncology : P54
Serum beta human chorionic gonadotrophin; does it have a role as a marker of disease recurrence after radical cystectomy for bladder cancer? : P55
A comparison of survey results from 514 pelvic surgeons - trends in robot-assisted surgery : P56
A comparison of open and laparoscopic cystectomy : P57
Outcomes of emergency renal embolisation - 7 year single centre analysis : P58
Robotic assisted laparoscopic partial nephrectomy: a prospective analysis of feasibility, operative and perioperative outcomes : P59
Is laparoscopic radical cystectomy safe? - results from a high volume UK centre : P60
Transluminal Surgery (TLS) A series of vesicoscopic procedures in women : P61
Rectus sheath catheters - a novel peri-operative pain control technique for open pelvic uro-oncology surgery : P62
Transperineal sector prostate biopsy technique and morbidity : P63
Consultant-delivered care - is it worth it? : P64
Development and validation of an iPad based laparoscopic trainer : P65
Which resources do medical undergraduates currently utilise in their studies? : P66
Can the productive operating theatre (Tpot) programme increase efficiency in urology operating theatres? : P67
Urological injury secondary to urogynaecology tape/mesh procedures : P68
The effect of Urethral Diverticulae on female voiding dynamics : P69
The effect of urethral diverticulum MRI configuration on the incidence of new onset urodynamic stress urinary incontinence following excision : P70
The efficacy and safety of intravesical sodium hyaluronate solution (cystistat®) installation in preventing recurrent Cystitis/Urinary Tract Infection in women : P71
Reduced innate beta-defensin-2 response in the bladder and vaginal epithelia increases suceptibility to flagellated : P72
A novel, patient-managed neuromodulation system (PMNS) that uses a noninvasive sacral patch for treatment of overactive bladder (OAB): effect on urgency incontinence in a prospective, multi-center, randomized trial : P73
Mixed growth of doubtful significance is on the contrary wholly significant in patients with LUTS : P74
Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity (IDO) : P75
Comparison study of OnabotulinumtoxinA 300U and 200U in patients with detrusor overactivity : P76
Can laser vapoenucleation and morcellation be the gold standard for surgical treatment of symptomatic prostatic obstruction? - initial UK experience using thulium laser : P77
DAY-CASE GYRUS TURP - is it feasible? : P78
A prospective, randomized comparison between the bipolar plasma enucleation of the prostate versus open prostatectomy in cases of prostates over 80 ml : P79
Holmium laser enucleation of the prostate in men with urinary retention - 5 year results : P80
Voiding parameters in the elderly male: the CHAMP study : P81
Prevalence & natural history of urinary symptoms in recreational ketamine users : P82
Erectile dysfunction treatment by Schedule 2: the setup at a NHS trust : P83
The first 20 months of a national audit of urethroplasty practice in the UK : P84
The role of the Artificial Urinary Sphincter (AUS) for Incontinence after radiotherapy for prostate cancer : P85
The management of extraperitoneal bladder rupture in blunt pelvic trauma : P86
Does Clean Intermittent Self Catheterisation (CISC) pose a risk of infection/erosion of an Artificial Urinary Sphincter (AUS) in patients with neuropathic bladder : P87
Bladder exstrophy in adults: a 20 year follow up : P88
Genital lichen sclerosus in men with penile carcinoma - a critical analysis : P89
Long-term oncological outcome following conservative surgery for squamous cell carcinoma of the penis : P90
Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the outcome of 500 inguinal basins assessed in a single institution : P91
Optimal follow-up arrangements for invasive squamous carcinoma of the penis : P92
Evaluating the role of contrast enhanced ultrasound in the assessment of complex renal lesions : P93
Can pre-operative CT accurately predict IVC wall invasion in cases with locally advanced renal cell carcinoma? : P94
Factors predicting oncological outcome in T3 renal cell carcinoma : P95
BAUS renal cancer surgical audit 2011: on behalf of BAUS section of oncology : P96
A Cancer Network Audit on partial nephrectomy for tumours <5 cm : P97
Predicting oncological outcomes following partial nephrectomy : P98
Aiming for zero ischemia partial nephrectomy (PN) - why clamp the hilar vessels? : P99
Signatured approach to robotic assisted laparoscopic partial nephrectomy based on tumour anatomy : P100
Zero ischaemia laparoscopic partial nephrectomy : P101
Percutaneous and laparoscopic cryotherapy for small renal tumours : P102
Magnetic Resonance Imaging (MRI) in the evaluation of Haematospermia - a single centre experience : U1
Iliopsoas abscess with urinary tract involvement: a case series and recommendations for management : U2
Do bladder cancer patients who miss out on the 2 week wait referral process have a worse prognosis? : U3
Analysis of 1015 patients with haematuria presenting to a protocol driven clinic. Does the current diagnostic practice need a change? : U4
Is cystoscopy required in the absence of haematuria? : U5
Urology as a specialty - are we becoming a catheter service? : U6
Review of epididimo-orchitis management in 3 UK centres: are we still not doing enough? : U7
Catheter associated urinary tract infections (CAUTIs) in a UK teaching hospital: what lessons can we learn? : U8
Suprapubic catheterisation in children: an audit of practice at a tertiary centre : U9
The Role of Micturating Cystourethrogram (MCUG) in the evaluation of recurrent urinary tract infections following renal transplantation : U10
Adult experience of circumcision under local anaesthetic defies consultant beliefs : U11
Parental perception of acute scrotal pain in children : U12
Management of post orchidectomy stage I classical seminoma: 10 year outcome data of a regional cancer unit : U13
Histological outcomes of orchidectomy performed for clinically and radiologically suspicious testicular pathology: a 15 year review : U14
The pocket ultrasound in urological clinical practice : U15
A retrospective review of acute scrotal pain requiring surgical exploration over a 10 year period: Implications for greater use of Doppler ultrasound : U16
The evolution and development of male urinary incontinence management : U17
A tribute to the life and accomplishments of Mathieu Jaboulay : U18
Al Zahrawi: the Sheikh of urological surgery of the tenth century : U19
The evolution of the condom: goats bladder to rubber latex : U20
Urological practices in the Ancient Americas : U21
Ronald Ogier Ward: urologist, military hero εt first President of BAUS : U22
Professor Gustav Simon (1824-1876) and the first successful nephrectomy : U23
De-circumcising the past: Aulus Cornelius Celcus's contribution to epispasm during the Hellenistic period (323 BCE-146 BCE) : U24
The Surgical Revolution after Lord Joseph Lister : U25
A bibliometric analysis of urological oncology research output over 55 years : U26
Ireland's contribution the evolution of open prostatic surgery : U27
Joaquin Maria Albarran Y Dominguez: a Cuban orphan to a Noble prize nominated Urologist : U28
The history of reporting of male genital self-mutilation and its association with psychotic illness : U29
History of scientific peer review in medicine, medical publications and urology journals : U30
Dr. John Macintyre (1857-1928) - an unknown ‘Spark’ in the field of uro-radiology : U31
The history of female urologists : U32
‘From bats and ships to prostate and kidneys’ A brief history of ultrasound in urology : U33
From TB to bladder cancer: The BCG story : U34
William Cheselden: the greatest lithotomist : U35
Obstruction or not? The history of the Whitaker test : U36
Donald Gleason - what a score: the history of the gold standard of histological grading for prostate cancer : U37
How bladder stones helped protect Britain from an ‘Integrated’ Europe 200 years ago : U38
Intravesical therapy for painful bladder syndrome : U39
The battle for TURP in UK! : U40
The history of the use of intravesical agents in superficial bladder cancer : U41
History of natural remedies for prostate disorders : U42